MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Chikungunya: An emerging arthropod borne disease presenting as rhombencephalitis with near complete recovery

    M. Shah, P. Shah, T. Singhal, K. Shetty, R. Syed, A. Aggarwal (Mumbai, India)

    Objective: To report the clinical course and good neurological outcome of severe Chikungunya rhombencephalitis. Background: Chikungunya is an emerging Aedes mosquito borne virus that is…
  • 2022 International Congress

    Concomitant Medication Use and Levodopa Equivalent Daily Dose Requirements After Foslevodopa/foscarbidopa Initiation

    D. Santos Garcia, L. Bergmann, B. Bergmans, F. Bergquist, S. Criswell, V. Fung, J. Jia, P. Kukreja, N. Pavasia, W. Robieson, Z. Zhang, D. Standaert (A Coruña, Spain)

    Objective: To evaluate patterns of concomitant medication use and levodopa equivalent daily dose (LEDD) during a 52 week study with foslevodopa/foscarbidopa (LDP/CDP). Background: LDP/CDP is…
  • 2022 International Congress

    Scoring Algorithm-Based Genomic Testing in Dystonia- A Validation study from a Single Centre Cohort from India

    VV. Holla, K. Neeraja, A. Stezin, M. Netravathi, N. Kamble, R. Yadav, PK. Pal (Bengaluru, India)

    Objective: To validate a recently introduced scoring algorithm predicting the diagnostic utility of exome sequencing for dystonia. Background: Despite the increasing availability of next generation…
  • 2022 International Congress

    Clinical and device-based predictors of improvement in motor experiences of daily living after a short-term multidisciplinary inpatient treatment: a cohort study

    R. Scherbaum, J. Oppermann, A. Moewius, V. Tschentscher, J. Geritz, J. Welzel, C. Hansen, R. Gold, W. Maetzler, L. Tönges (Bochum, Germany)

    Objective: To determine predictors of improvement in motor experiences of daily living (m-EDL) after a multidisciplinary inpatient ‘PD multimodal complex treatment’ (PD-MCT) and clarify the…
  • 2022 International Congress

    Pilot study of narrative medicine (NM) interventions in facilitating advance care planning (ACP) in Parkinson’s disease (PD): a feasibility study

    J. Jiao, B. Lobb, A. Hiller (Portland, USA)

    Objective: To demonstrate the feasibility of conducting NM interventions in PD and to describe NM’s potential impact upon ACP. Background: ACP is associated with increased…
  • 2022 International Congress

    Neuroimaging in Glucocerebrosidase-associated parkinsonism: a systematic review

    R. Balestrino, F. Agosta, S. Basaia, M. Filippi (Milano, Italy)

    Objective: To critically review studies applying neuroimaging to Glucocerebrosidase (GBA)-associated parkinsonism. Background: Mutations in the GBA gene cause Gaucher disease (GD) and constitute the most…
  • 2022 International Congress

    Changes in botulinum toxin dosing in cervical dystonia over 7 years

    S. Rafee, M. Hutchinson (Dublin, Ireland)

    Objective: To assess changes in botulinum toxin dosing over the course of illness of cervical dystonia. Background: Muscle specific botulinum toxin injections remains the main…
  • 2022 International Congress

    TWO-DIMENSIONAL SMOOTH PURSUIT TESTS FOR EARLY PARKINSON’S DISEASE IDENTIFICATION

    E. Luque-Buzo, A. Burlaka-Petrash, J. Gómez-García, M. Bejani, M. Del Valle-Loarte, F. Grandas, J. Godino-Llorente (Madrid, Spain)

    Objective: To report qualitative analysis of smooth pursuit (SP) abnormalities found in early Parkinson´s disease (PD) patients using one- and two-dimensional test. Background: The eye…
  • 2022 International Congress

    Preliminary data on multimodal approach for early characterization of Parkinson’s disease (PD) and Multiple System Atrophy (MSA), a prospective study with connected insoles

    F. Marchand, L. Farid, J. Labreuche, R. Viard, L. Defebvre, D. Devos, A. Mathieu, L. Kjaersgaard, AK. Berger, D. Meulien, V. Terebaite, JC. Brasen, C. Moreau (LILLE, France)

    Objective: Early analysis to evaluate changes in gait parameters as assessed on standardized and ecological conditions and their association to markers of disease progression, i.e.,…
  • 2022 International Congress

    A clinico-genetic study based on the Innsbruck MSA Registry

    F. Leys, S. Eschlboeck, N. Campese, P. Mahlknecht, M. Peball, V. Sidoroff, R. Granata, V. Bonifati, J. Zschocke, S. Kiechl, W. Poewe, K. Seppi, GK. Wenning, A. Fanciulli (Innsbruck, Austria)

    Objective: To assess family history (FH) for neurodegenerative disorders in people with multiple system atrophy (MSA), compare its prevalence with that of a prospectively recruited…
  • « Previous Page
  • 1
  • …
  • 625
  • 626
  • 627
  • 628
  • 629
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley